Obesity Protocol Targeting and Investigational Option for a New weight loss Solution.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs AOD 9604 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms OPTIONS
- Sponsors Calzada
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12605000067673).
- 12 Oct 2006 The expected completion date for this trial is now 1 Dec 2006.
- 12 Oct 2006 New trial record.